298 related articles for article (PubMed ID: 18855648)
1. Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.
Undrovinas A; Maltsev VA
Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):348-59. PubMed ID: 18855648
[TBL] [Abstract][Full Text] [Related]
2. Late sodium current in failing heart: friend or foe?
Maltsev VA; Undrovinas A
Prog Biophys Mol Biol; 2008; 96(1-3):421-51. PubMed ID: 17854868
[TBL] [Abstract][Full Text] [Related]
3. Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences.
Maltsev VA; Reznikov V; Undrovinas NA; Sabbah HN; Undrovinas A
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1597-608. PubMed ID: 18203851
[TBL] [Abstract][Full Text] [Related]
4. Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its beta1 subunit.
Maltsev VA; Kyle JW; Undrovinas A
J Physiol Sci; 2009 May; 59(3):217-25. PubMed ID: 19340536
[TBL] [Abstract][Full Text] [Related]
5. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability.
Maltsev VA; Silverman N; Sabbah HN; Undrovinas AI
Eur J Heart Fail; 2007 Mar; 9(3):219-27. PubMed ID: 17067855
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
Undrovinas AI; Belardinelli L; Undrovinas NA; Sabbah HN
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1(Suppl 1):S169-S177. PubMed ID: 16686675
[TBL] [Abstract][Full Text] [Related]
7. Late sodium current is a novel target for amiodarone: studies in failing human myocardium.
Maltsev VA; Sabbah HN; Undrovinas AI
J Mol Cell Cardiol; 2001 May; 33(5):923-32. PubMed ID: 11343415
[TBL] [Abstract][Full Text] [Related]
8. Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human heart failure.
Trenor B; Cardona K; Gomez JF; Rajamani S; Ferrero JM; Belardinelli L; Saiz J
PLoS One; 2012; 7(3):e32659. PubMed ID: 22427860
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure.
Mishra S; Undrovinas NA; Maltsev VA; Reznikov V; Sabbah HN; Undrovinas A
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1596-605. PubMed ID: 21705762
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of the cardiac late Na current and its potential as a drug target.
Moreno JD; Clancy CE
J Mol Cell Cardiol; 2012 Mar; 52(3):608-19. PubMed ID: 22198344
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
12. Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes.
Weisser-Thomas J; Piacentino V; Gaughan JP; Margulies K; Houser SR
Cardiovasc Res; 2003 Mar; 57(4):974-85. PubMed ID: 12650875
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.
Belardinelli L; Shryock JC; Fraser H
Heart; 2006 Jul; 92 Suppl 4(Suppl 4):iv6-iv14. PubMed ID: 16775092
[TBL] [Abstract][Full Text] [Related]
14. Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts.
Mishra S; Reznikov V; Maltsev VA; Undrovinas NA; Sabbah HN; Undrovinas A
J Physiol; 2015 Mar; 593(6):1409-27. PubMed ID: 25772296
[TBL] [Abstract][Full Text] [Related]
15. The effect of SN-6, a novel sodium-calcium exchange inhibitor, on contractility and calcium handling in isolated failing rat ventricular myocytes.
Gandhi A; Siedlecka U; Shah AP; Navaratnarajah M; Yacoub MH; Terracciano CM
Cardiovasc Ther; 2013 Dec; 31(6):e115-24. PubMed ID: 24106913
[TBL] [Abstract][Full Text] [Related]
16. Sodium ion transporters as new therapeutic targets in heart failure.
Baartscheer A; van Borren MM
Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):229-36. PubMed ID: 18855635
[TBL] [Abstract][Full Text] [Related]
17. First report on an inotropic peptide activating tetrodotoxin-sensitive, "neuronal" sodium currents in the heart.
Kirchhof P; Tal T; Fabritz L; Klimas J; Nesher N; Schulte JS; Ehling P; Kanyshkova T; Budde T; Nikol S; Fortmueller L; Stallmeyer B; Müller FU; Schulze-Bahr E; Schmitz W; Zlotkin E; Kirchhefer U
Circ Heart Fail; 2015 Jan; 8(1):79-88. PubMed ID: 25424392
[TBL] [Abstract][Full Text] [Related]
18. The late Na current as a therapeutic target: where are we?
Maier LS; Sossalla S
J Mol Cell Cardiol; 2013 Aug; 61():44-50. PubMed ID: 23500390
[TBL] [Abstract][Full Text] [Related]
19. Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice.
Yao L; Fan P; Jiang Z; Viatchenko-Karpinski S; Wu Y; Kornyeyev D; Hirakawa R; Budas GR; Rajamani S; Shryock JC; Belardinelli L
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C577-86. PubMed ID: 21677263
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
